LAMBDA-CAP
Live / Registered — Registered (as of 11 Feb 2020)
What this means for you
Registered since 11 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79250615
- Registration number
- 5980170
- Mark type
- Stylized text
- Filed
- 03 Dec 2018
- Published for opposition
- 26 Nov 2019
- Registered
- 11 Feb 2020
- Attorney of record
- Dennis S. Prahl
Goods and services
- Class 001 — Chemicals: Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research
Owner
Prosecution history
- 05 Feb 2026 — TEAS SECTION 71 & 15 RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 31 Dec 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 27 Aug 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Aug 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Jun 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 May 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 May 2020 — FINAL DISPOSITION PROCESSED
- 11 May 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2019 — PUBLISHED FOR OPPOSITION
- 06 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Oct 2019 — ASSIGNED TO LIE
- 16 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER